Co-Diagnostics, Inc. (NASDAQ:CODX) announced on Monday that it has entered into a joint venture agreement with the Kingdom of Saudi Arabia (KSA) based Arabian Eagle Manufacturing.
The agreement aims to research, develop, manufacture, assemble, distribute, and commercialize Co-Dx technologies and intellectual property, including the company's upcoming Co-Dx PCR point-of-care platform in KSA and 18 other countries across the Middle East and North Africa regions.
